NYSE : KVUE

Kenvue Inc.

$18.7 USD

-$0.06 (-0.32%)

Volume
14.01M
Average Volume
20.24M
Market Capitalization
$35.9B
P/E Ratio
22.00
Dividend Yield
4.44%
Price Target
$18.00
Year High
$22.87
Year Low
$14.02
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.98
Source Headline
US appeals court revives private lawsuits linking Tylenol to autism, ADHD

A federal appeals ​court on Monday ‌revived hundreds of private lawsuits against ​Kenvue and many ​pharmacies and retailers, alleging ⁠that the ​Tylenol painkiller causes autism ​and attention deficit hyperactivity order.

reuters.com - 2026-07-13 10:54:59

This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026

Kimberly-Clark is far from flashy, but what it lacks in glitz and glam, it makes up for with predictability.

fool.com - 2026-07-08 08:05:00

2 Dividend Kings to Buy and Hold Forever

Dividend Kings are companies that have increased their dividend payments for at least 50 consecutive years. Automatic Data Processing has seen its share price drop over concerns about unemployment.

fool.com - 2026-07-08 06:00:00

3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now

Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash, growing earnings, and reaffirming guidance.

247wallst.com - 2026-07-07 13:19:51

5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential

Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.

247wallst.com - 2026-07-02 08:18:39

5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026

EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies for 2H 2026.

zacks.com - 2026-06-30 09:40:25

5 High-Yielding Dividend Kings Retirees and Boomers Can Buy Today and Safely Hold Forever

While many Baby Boomers have enjoyed a long bull market over the past 35 years, there comes a point when income becomes more critical than stock appreciation. The reason is simple: those who leave their careers to enjoy a well-deserved retirement lose the benefits of a regular salary and their jobs, such as 401(k) matching... 5 High-Yielding Dividend Kings Retirees and Boomers Can Buy Today and Safely Hold Forever

247wallst.com - 2026-06-25 08:46:13

Where to Put $1,000 When the Market Is This Uncertain

Church & Dwight's volume-driven growth, Keurig Dr Pepper's expanding energy drink portfolio, and Kenvue's strong beauty segment show these companies are finding ways to grow beyond simply passing inflation on to customers. None of these stocks are likely to be overnight winners, but their strong brands, cash generation, and long-term growth opportunities make them compelling choices for investors looking to put $1,000 to work in a volatile market.

fool.com - 2026-06-20 04:05:00

Boomers Need the Safest Dividend Stocks. We Asked Claude and Found 5 That Yield 5% or More

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.

247wallst.com - 2026-06-18 08:45:48

1 Dividend King to Buy Hand Over Fist Right Now

Stockholders have approved Kenvue's merger with Kimberly-Clark. The resulting merger is between two Dividend Kings.

fool.com - 2026-06-17 14:45:00

Best Consumer Dividend Stocks to Buy Now: HAS, KVUE, MOV

Here are three top-rated consumer dividend stocks that have yields above 3% and have made their way onto the coveted Zacks Rank #1 (Strong Buy) list.

zacks.com - 2026-06-04 20:26:07

Diamond Hill Select Fund Q1 2026 Portfolio Update

Diamondback Energy's shares rose as the sharp rise in oil prices drove a broad rally across US-based oil producers. Consumer finance company Capital One underperformed during the quarter following its announced acquisition of Brex, an AI-native commercial fintech platform. We added global consumer staples leader Kimberly-Clark to the portfolio following its announced acquisition of Kenvue and subsequent share price decline.

seekingalpha.com - 2026-05-26 13:15:00

Best Income Stocks to Buy for May 26th

GECC, KVUE and TNET made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 26, 2026.

zacks.com - 2026-05-26 10:05:43

KVUE or LRLCY: Which Is the Better Value Stock Right Now?

Investors with an interest in Consumer Products - Staples stocks have likely encountered both Kenvue (KVUE) and L'Oreal SA (LRLCY). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-05-25 12:40:19

Kimberly-Clark positioned for long-term value creation following Kenvue deal, says Bank of America

Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy' rating and $120 price objective from Bank of America analysts, who believe that the company's acquisition of Kenvue assets could create long-term value despite near-term integration challenges. The analysts said the deal appears opportunistic, noting the acquisition multiple of about 14 times Kenvue's last-twelve-month adjusted EBITDA and a purchase price of $21.01 per share, roughly in line with Kenvue's market value before Tylenol-related headlines weighed on the stock in September 2025.

proactiveinvestors.com - 2026-05-14 15:30:55

New Strong Buy Stocks for May 11th

TNET, LSCC, STRL, CIVB and KVUE have been added to the Zacks Rank #1 (Strong Buy) List on May 11th, 2026.

zacks.com - 2026-05-11 07:01:08

Best Income Stocks to Buy for May 11th

KVUE, BP and CIVB made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 11th, 2026.

zacks.com - 2026-05-11 04:31:07

Kenvue (KVUE) Q1 Earnings and Revenues Beat Estimates

Kenvue (KVUE) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.24 per share a year ago.

zacks.com - 2026-05-07 09:55:57

5 Things to Know Before the Stock Market Opens

Stock futures are treading water this morning as investors await the latest news on a potential peace deal with Iran and digest a slew of earnings reports; oil prices are falling again this morning amid optimism that the Strait of Hormuz could reopen soon; Arm Holdings shares are falling after the company cited a lack of supply and declining smartphone demand in its latest earnings report; shares of McDonald's and Shell are gaining ground after their earnings topped Wall Street estimates; and DoorDash shares are soaring after the food delivery platform reported solid results and issued a rosy outlook for orders. Here's what you need to know today.

investopedia.com - 2026-05-07 09:11:11

$100,000 in Our Dividend Kings Portfolio Will Generate $5,400 in Passive Income Each Year

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.

247wallst.com - 2026-05-07 08:15:36

These 3 Dividend Stocks Have Made Investors Rich. They Can Do It Again.

Hershey is shifting from cost pressure to earnings expansion amid collapsing cocoa prices, aiding growth recovery and the dividend. General Mills offers an unusually high 7% yield because of temporary headwinds, while restructuring and its pet food segment provide a path back to stability.

fool.com - 2026-05-07 08:15:00

Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark

Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its ​skin health and beauty brands.

reuters.com - 2026-05-07 07:15:47

Kenvue Reports First Quarter 2026 Results

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal first quarter ended March 29, 2026. “Our year is off to an encouraging start, as our continued efforts to strengthen the business and sharpen execution resulted in delivering net and organic sales growth for the second consecutive quarter, along with meaningful year-over-year improvement in gross margin, operating margin, and EPS,” said Kirk Perry, Chief Executive Officer. “We remain confide.

businesswire.com - 2026-05-07 06:30:00

Kenvue Declares Quarterly Cash Dividend

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on May 27, 2026, to shareholders of record as of the close of business on May 13, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Li.

businesswire.com - 2026-04-29 06:45:00

This 5-Stock “Super Staples” Portfolio Yields Up To 11.3%

Consumer staples are boring and reliable. And they typically pay generous dividends.

forbes.com - 2026-04-26 09:40:16

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2026 financial results before the market opens on May 7, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company's website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century.

businesswire.com - 2026-04-23 16:32:00

Kimberly-Clark: This 5% Yielder Is A Buy Ahead Of The Kenvue Merger

I am upgrading Kimberly-Clark shares to a buy ahead of the planned Kenvue merger. The Kenvue deal offers significant cost synergies, enhanced bargaining power, and will position the entity as one of the industry's largest players. The company has raised its dividend for 53 consecutive years and shares currently yield more than 5%.

seekingalpha.com - 2026-04-20 17:33:45

The Smartest Dividend Stocks to Buy With $2,000 Right Now

After its product lineup faced a long-lasting headwind, beverage outfit PepsiCo may finally be back on track. Johnson & Johnson spinoff Kenvue is built for reliable recurring income.

fool.com - 2026-04-19 16:05:00

Brokerages Set Kenvue Inc. (NYSE:KVUE) Target Price at $19.50

Kenvue Inc. (NYSE: KVUE - Get Free Report) has been assigned an average rating of "Hold" from the sixteen research firms that are presently covering the stock, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among

defenseworld.net - 2026-04-17 01:44:49

Kimberly-Clark's New Structure Sets Stage for Kenvue Integration

Kimberly-Clark's lean new regional structure is built for speed as it prepares to integrate Kenvue in a $48.7B deal closing in H2 2026.

zacks.com - 2026-04-16 10:10:14

Get KVUE Insider Trade Alerts

KVUE Price Target Summary

Last Month

$20.00

1 analysts

Last Quarter

$20.00

1 analysts

Last Year

$18.58

12 analysts

All Time

$21.00

22 analysts

KVUE Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-04-15 Citigroup Maintain Neutral Neutral
2026-04-14 Barclays Maintain Equal Weight Equal Weight
2026-04-07 UBS Maintain Neutral Neutral
2026-03-06 Barclays Maintain Equal Weight Equal Weight
2026-02-18 UBS Maintain Neutral Neutral
2026-02-18 Citigroup Maintain Neutral Neutral
2026-02-18 Canaccord Genuity Maintain Hold Hold
2026-01-30 Jefferies Downgrade Buy Hold
2025-11-10 Barclays Maintain Equal Weight Equal Weight
2025-10-29 Canaccord Genuity Downgrade Buy Hold
2025-10-27 Jefferies Maintain Buy Buy
2025-10-10 JP Morgan Maintain Overweight Overweight
2025-10-09 Citigroup Maintain Neutral Neutral
2025-10-08 B of A Securities Maintain Buy Buy
2025-10-08 UBS Maintain Neutral Neutral
2025-10-02 Goldman Sachs Maintain Neutral Neutral
2025-10-01 Barclays Maintain Equal Weight Equal Weight
2025-09-26 Rothschild & Co Upgrade Neutral Buy
2025-09-23 Evercore ISI Group Maintain In Line In Line
2025-09-16 Citigroup Maintain Neutral Neutral
2025-09-08 Evercore ISI Group Maintain In Line In Line
2025-08-08 RBC Capital Maintain Sector Perform Sector Perform
2025-08-08 Canaccord Genuity Maintain Buy Buy
2025-07-25 JP Morgan Maintain Overweight Overweight
2025-07-17 UBS Maintain Neutral Neutral
2025-07-15 B of A Securities Maintain Buy Buy
2025-07-15 Citigroup Maintain Neutral Neutral
2025-07-15 Barclays Maintain Equal Weight Equal Weight
2025-05-12 Barclays Maintain Equal Weight Equal Weight
2025-05-09 UBS Maintain Neutral Neutral
2025-05-09 Citigroup Maintain Neutral Neutral
2025-04-14 Citigroup Maintain Neutral Neutral
2025-04-14 Barclays Maintain Equal Weight Equal Weight
2025-03-27 Barclays Maintain Equal Weight Equal Weight
2025-03-05 Canaccord Genuity Maintain Buy Buy
2025-02-24 Piper Sandler Maintain Overweight Overweight
2025-02-07 Canaccord Genuity Maintain Buy Buy
2025-02-07 UBS Maintain Neutral Neutral
2025-02-03 RBC Capital Maintain Sector Perform Sector Perform
2025-01-17 Barclays Maintain Equal Weight Equal Weight
2025-01-16 UBS Maintain Neutral Neutral
2025-01-15 Citigroup Maintain Neutral Neutral
2025-01-06 Piper Sandler Upgrade Neutral Overweight
2024-12-12 Deutsche Bank Downgrade Buy Hold
2024-10-22 B of A Securities Maintain Buy Buy
2024-10-11 JP Morgan Maintain Overweight Overweight
2024-09-24 RBC Capital Downgrade Outperform Sector Perform
2024-09-23 Piper Sandler Maintain Neutral Neutral
2024-08-07 JP Morgan Maintain Overweight Overweight
2024-08-07 RBC Capital Maintain Outperform Outperform
2024-08-07 UBS Maintain Neutral Neutral
2024-08-07 Deutsche Bank Maintain Buy Buy
2024-07-25 Deutsche Bank Maintain Buy Buy
2024-07-22 JP Morgan Maintain Overweight Overweight
2024-07-10 Citigroup Maintain Neutral Neutral
2024-05-08 HSBC Maintain Hold Hold
2024-03-04 Goldman Sachs Maintain Neutral Neutral
2024-03-01 Goldman Sachs Downgrade Buy Neutral
2024-02-13 RBC Capital Maintain Outperform Outperform
2024-02-09 RBC Capital Maintain Outperform Outperform
2024-02-09 JP Morgan Maintain Overweight Overweight
2023-12-19 UBS Maintain Neutral Neutral
2023-10-10 Goldman Sachs Maintain Buy Buy
2023-10-04 JP Morgan Maintain Overweight Overweight
2023-09-11 Deutsche Bank Upgrade Hold Buy
2023-08-24 Goldman Sachs Upgrade Neutral Buy
2023-08-17 RBC Capital Maintain Outperform Outperform
2023-07-21 Citigroup Maintain Neutral Neutral